Switching to venetoclax led to sustained high rates of undetectable minimal residual disease, the investigators found.

Personalized exercise guidance is needed for people living with chronic lymphocytic leukemia (CLL), the most common type of ...

CLL Society, the world's leading authority for chronic lymphocytic leukemia and small lymphocytic lymphoma patients, has announced the recipients of its 2025 Research Program awards. This year, three ...

Discover how exercise programs and personalized guidance contribute to positive impact on symptoms and quality of life in ...

To combat the onslaught of litigation, Bayer has been pushing legislation in nine states, that would shield the company from ...

Worsening a patient's credit can prevent them from getting a job, renting an apartment, or even paying their outstanding ...

During a live event, Andrew H. Lipsky, MD, and participants discussed balancing efficacy, safety, and patient preferences ...

Troy woman writes about her experience as a caregiver for her late husband to explore themes of love, grief and the human ...

In a recent social media post, Peter Ray, senior director of medicinal chemistry at Recursion Pharmaceuticals, Inc.

The CEO of Pivotal Advisors, Tiffany McGhee, spoke on CNBC on June 27 on what investors should do in light of the current ...

Michelle Xia gained experience at U.S. pharmaceutical firms before launching her own biotech company back home in China. In a ...

A leukemia patient’s health is getting dangerously worse in an ICE detention center. Arbella Rodríguez Márquez, a legal resident of the United States, suffers from chronic lymphocytic leukemia. The ...